Skip to main content
OpenTrials

Clinical trial condition

Graves Ophthalmopathy

Explore clinical trials studying Graves Ophthalmopathy. Study availability and eligibility vary by location and protocol.

143 public trials 34 recruiting studies
Refine in advanced search Browse all conditions

Graves Ophthalmopathy trial results

Enrolling by invitation

Multi-center Prospective Clinical Study on Glucocorticoid Pulse Therapy for Graves' Ophthalmopathy (GO)

NCT06693856

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +11 more
Locations
  • Shanghai Changzhen Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Changhai Hospital Shanghai, Shanghai Municipality, China
  • Shanghai Longhua Hospital Shanghai, Shanghai Municipality, China
View Trial Details
Active, not recruiting

A Study to Assess the Efficacy and Safety of ZL-1109 in Chinese Participants With Active Thyroid Eye Disease

NCT07211776

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Site01006 Beijing, China
  • Site01009 Beijing, China
  • Site01010 Beijing, China
  • Site01029 Bengbu, China
View all 26 locations
View Trial Details
Active, not recruiting

A Trial Investigating Lu AG22515 in Adult Participants With Moderate-to-Severe Thyroid Eye Disease

NCT06557850

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Diagnostic-Consultative Center Alexandrovska Sofia, Bulgaria
  • University Clinical Centre of the Republic of Srpska - Oncology Clinic Banja Luka, Republika Srpska, Bosnia and Herzegovina
  • Medical University of Sofia (MUS)-University Specialized Hospital for Active Treatment of Endocri... Sofia, Sofia City Province, Bulgaria
  • Uniwersytet Jagiellonski Collegium Medicum (Jagiellonian University Medical College) Krakow, Lesser Poland Voivodeship, Poland
View Trial Details
Active, not recruiting

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Active Thyroid Eye Disease (TED)

NCT06625411

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Alliance Research Institute - Canoga Park Canoga Park, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • United Medical Research Institute Inglewood, California, United States
View all 48 locations
View Trial Details
Active, not recruiting

An Efficacy, Safety, and Tolerability Study of VRDN-003 in Participants With Chronic Thyroid Eye Disease (TED)

NCT06625398

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Scottsdale Clinical Trials Scottsdale, Arizona, United States
  • Alliance Research Institute - Canoga Park Canoga Park, California, United States
  • Marvel Clinical Research Huntington Beach, California, United States
  • United Medical Research Institute Inglewood, California, United States
View all 60 locations
View Trial Details
Active, not recruiting

A Study of AMG 732 in Healthy Participants and Participants With Thyroid Eye Disease

NCT06401044

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Applied Research Center of Arkansas Little Rock, Arkansas, United States
  • Amy Patel Jain MD Newport Beach, California, United States
  • Levenson Eye Associates Jacksonville, Florida, United States
  • Ilumina Medical Research Kissimmee, Florida, United States
View all 44 locations
View Trial Details
Active, not recruiting

A Trial to Investigate Teprotumumab Subcutaneous Administration Compared With Placebo in Male and Female Adult Participants With Moderate-to-severe Active Thyroid Eye Disease

NCT06248619

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care - NVISION - PPDS Tucson, Arizona, United States
  • Advanced Quality Medical Research Orland Park, Illinois, United States
  • W Kellogg Eye Center Ann Arbor, Michigan, United States
  • Las Vegas Endocrinology Henderson, Nevada, United States
View all 38 locations
View Trial Details
Active, not recruiting

A Safety and Tolerability Study of VRDN-003 in Participants With Thyroid Eye Disease (TED)

NCT06812325

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • Catalina Eye Care Tuscon, Arizona, United States
  • United Medical Research Institute Inglewood, California, United States
  • Orbital Plastics Newport Beach, California, United States
  • California Eye Specialists Medical Group INC Pasadena, California, United States
View all 64 locations
View Trial Details

Related conditions